Jove
Visualize
Contact Us

Related Experiment Videos

Interpretation with hindsight.

John Ansell1

  • 1Division of Oncology, School of Molecular and Clinical Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK.

European Journal of Cancer (Oxford, England : 1990)
|August 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PRO-CAR-T™ study: achieving excellence in patient and public involvement and engagement.

Journal of patient-reported outcomes·2026
Same author

Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus study.

EClinicalMedicine·2025
Same author

Protocol for a mixed-methods study to develop and feasibility test a digital system for the capture of patient-reported outcomes (PROs) in patients receiving chimeric antigen receptor T-cell (CAR-T) therapies (the PRO-CAR-T study).

BMJ open·2024
Same author

Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells.

Molecular and cellular biology·2004
Same author

Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (HSC/RUs): role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver.

Development (Cambridge, England)·2002
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sandritter

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • This work reviews Sandritter's 1965 findings on tumor DNA content.
  • It examines the evolution of methodologies used to measure DNA in tumors.
  • The study analyzes the relationship between DNA content and tumor pathology/progression.

Discussion:

  • The interpretation traces the advancements in tumor DNA content analysis.
  • It critically evaluates Sandritter's initial conclusions and hypotheses.
  • The discussion considers these findings within the context of contemporary scientific understanding.

Key Insights:

  • Sandritter's early work established a link between tumor DNA and disease characteristics.
  • Methodological advancements have refined the understanding of DNA content in tumors.

Related Experiment Videos

  • The paper provides a historical perspective on DNA ploidy analysis in oncology.

    • Outlook:

    • Future research can build upon these foundational studies.
    • Continued investigation into DNA content may reveal new diagnostic markers.
    • Understanding historical data is crucial for advancing cancer research.